JSL Health Capital is a Washington, DC-based venture capital firm and venture studio that invests in late seed and growth-stage healthcare companies leveraging AI, data, and software. The firm funds, partners with, and builds transformational healthcare companies at the intersection of healthcare, AI, and data science.
38% of their portfolio is in Healthcare. Deal activity increased 33% year-over-year (4 deals in the last 12 months). Average disclosed round size is $66.2M (across 12 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series A
Last 12 Mo
4
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Precision | Series D | $250M | Sep 2026 |
 Beacon Biosignals | Unknown | $97M | Apr 2026 |
 Radial | Unknown | $50M | Dec 2025 |
| Beacon Biosignals | Series B | $99.0M | Sep 2025 |
 Bicycle Health | Series B | $16.5M | Jan 2025 |
| Radial | Series A | $50M | Jan 2025 |
| RRIPPL Care | Series A | $23M | Oct 2024 |
 Rippl | Series A | — | Oct 2024 |
| RRIPPL Care | Series A | $55M | Jan 2024 |
| Rippl | Series A | $55M | Jan 2024 |
 Synfini | Unknown | $8.9M | — |
 Network Bio | Unknown | $50M | — |
 Connie Health | Series B | $40M | — |
Top Co-Investors
General Catalyst8 shared
Kin Ventures4 shared
Mass General Brigham Ventures4 shared
F-Prime Capital4 shared
1843 Capital4 shared
ARCH Venture Partners4 shared
Solari Capital2 shared
BoxGroup2 shared
Scrub Capital2 shared
Founder Collective2 shared
Samsung Next2 shared
Gaingels1 shared
Foothill Ventures1 shared
The Blue Venture Fund1 shared
Breyer Capital1 shared
Founders Fund1 shared
Integra Partners1 shared
Quiet Capital1 shared
Cavallo Ventures1 shared
SignalFire1 shared
Last updated: 8 November 2026